Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/10/2025

Management of Anticoagulation after Renal Biopsy

Introduction to Anticoagulation Management

  • The American Society of Nephrology recommends that warfarin and antiplatelet agents can be reiniciated after a renal biopsy, with warfarin typically restarted the day after the biopsy and antiplatelet agents restarted 48-72 hours after the biopsy 1

Anticoagulation Therapy

  • Warfarin can be reiniciated the day after a renal biopsy, according to the American College of Cardiology 1
  • Antiplatelet agents can be reiniciated 48-72 hours after a renal biopsy, as suggested by the American Heart Association 1
  • The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) recommends stopping heparin before renal biopsy to minimize the risk of bleeding complications 2
  • Unfractionated heparin (UFH) should be stopped before the procedure due to its short half-life, while low molecular weight heparin (LMWH) should be stopped at least 24 hours before the procedure 2
  • Warfarin should be stopped 5 days before the procedure to minimize the risk of bleeding complications 2, 1

Risk Factors for Bleeding

  • Several factors increase the risk of bleeding after renal biopsy, including anticoagulant use (heparin, warfarin, DOACs), antiplatelet agents (aspirin, P2Y12 inhibitors), renal dysfunction (especially with GFR <30 ml/min), hypertension (uncontrolled blood pressure on day of procedure), and coagulation abnormalities (thrombocytopenia, prolonged PT/INR) 2

Bridging Therapy

  • For patients at high risk of thromboembolism (mechanical heart valves, recent thrombosis), bridging therapy with UFH may be necessary when LMWH or warfarin is stopped 3, 4
  • The timing of UFH bridging should be stopped 4-6 hours before the procedure, and monitoring of aPTT is recommended before proceeding with biopsy 3, 4

Resumption of Anticoagulation

  • Heparin can be resumed once adequate hemostasis has been achieved, typically 24-48 hours after an uncomplicated biopsy 3, 5
  • For high bleeding risk procedures, consider waiting 48-72 hours before resuming full anticoagulation 3, 5